The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML).
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Orsenix; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Celgene; Jazz Pharmaceuticals; Orsenix; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Merck; Seagen; Selvita; Sunesis Pharmaceuticals; Xencor
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Agios; Amgen; argenx; Astellas Pharma; BiolineRx; BiVictriX; Boston Biomedical; Covagen; Daiichi Sankyo; Emergent Biosolutions; Janssen; Jazz Pharmaceuticals; Kite, a Gilead company; Macrogenics; Newlink Genetics; Pfizer; Race Oncology
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Agios (Inst); Amgen (Inst); Aptevo Therapeutics; Arog (Inst); BiolineRx (Inst); Celgene; Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Pfizer; Seagen (Inst); Selvita (Inst); Stemline Therapeutics (Inst)
 
Marion Subklewe
Consulting or Advisory Role - Amgen; Celgene; Gilead Sciences; Janssen; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Amgen; Celgene; Gilead Sciences
Research Funding - Amgen; Gilead Sciences; Miltenyi Biotec; MorphoSys; Roche
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Pfizer
 
Veit Buecklein
Consulting or Advisory Role - Amgen; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Kite/Gilead
 
Mojca Jongen-Lavrencic
No Relationships to Disclose
 
Peter Paschka
Consulting or Advisory Role - Agios; Astellas Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Sunesis Pharmaceuticals
Speakers' Bureau - Agios; Astellas Pharma; Jazz Pharmaceuticals; Jazz Pharmaceuticals (Inst); Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen Oncology
 
Gert J. Ossenkoppele
Consulting or Advisory Role - Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Johnson & Johnson; Johnson & Johnson; Novartis; Novartis; Pfizer; Pfizer; Roche; Roche; Seagen; Seagen
Research Funding - Becton Dickinson; Becton Dickinson; Celgene; Celgene; ImmunoGen; ImmunoGen; Johnson & Johnson; Johnson & Johnson; Novartis; Novartis
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Antreas Hindoyan
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Suresh K Agarwal
Employment - Amgen
Stock and Other Ownership Interests - Abbvie; Amgen
 
Tian Dai
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Sophia Khaldoyanidi
Employment - Amgen
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Amgen
 
Anthony Selwyn Stein
Consulting or Advisory Role - Amgen; Stemline Therapeutics
Speakers' Bureau - Amgen; Stemline Therapeutics